Murdoch Childrens Research Institute
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- Holding
- Established
- 1986-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.mcri.edu.au
Using a Speech-Generating Device to Support Communication in Childhood Dementia
Not Applicable
Not yet recruiting
- Conditions
- Childhood DementiaGenetic DiseaseNonverbal CommunicationAugmentative and Alternative Communication
- First Posted Date
- 2025-06-26
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 38
- Registration Number
- NCT07039084
- Locations
- 🇦🇺
Murdoch Children's Research Institute, Melbourne, Victoria, Australia
Wearable Technology and Machine Learning for Early Detection and Risk Assessment of Unacceptable Toxicities in a Paediatric Oncology Cohort
Not yet recruiting
- Conditions
- CancerInfectionDigital HealthWearable Devices
- First Posted Date
- 2025-06-22
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 150
- Registration Number
- NCT07030998
- Locations
- 🇦🇺
The Royal Children's Hospital, Parkville, Victoria, Australia
A Strep Throat Controlled Human Infection Trial in Healthy Adults
Early Phase 1
Not yet recruiting
- Conditions
- Streptococcus Pyogenes PharyngitisStreptococcus Infection
- Interventions
- Biological: Streptococcus pyogenes M1UK strain MCRI0102
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 50
- Registration Number
- NCT06992141
- Locations
- 🇦🇺
Doherty Clinical Trials Ltd, Melbourne, Victoria, Australia
Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation
Phase 4
Not yet recruiting
- Conditions
- AllergyImmunotherapyVenom Allergy
- First Posted Date
- 2025-04-20
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 100
- Registration Number
- NCT06935890
- Locations
- 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇦🇺Royal Hobart Hospital, Hobart, Tasmania, Australia
🇦🇺Monash Medical Centre, Clayton, Victoria, Australia
HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation
Phase 1
Not yet recruiting
- Conditions
- Scabies
- Interventions
- Drug: ivermectin infant formula preparationDrug: Standard ivermectin 3mg tablet
- First Posted Date
- 2025-04-09
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 52
- Registration Number
- NCT06918665
- Locations
- 🇦🇺
The Royal Children's Hospital, Melbourne, Victoria, Australia
Investigating the Efficacy of a Paediatric Fertility Preservation Decision Aid in Parents and Adolescents and Young Adults (CAYA) Cancer Survivors
Not Applicable
Not yet recruiting
- Conditions
- Unmet Fertility Information Needs
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 358
- Registration Number
- NCT06894810
- Locations
- 🇦🇺
Murdoch Children's Research Institute, Melbourne, Victoria, Australia
Allergic Rhinitis Improvement Through Strategic Education: The ARISE Trial
Not Applicable
Not yet recruiting
- Conditions
- Allergy
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 194
- Registration Number
- NCT06686446
- Locations
- 🇦🇺
Murdoch Children's Research Institute, Parkville, Victoria, Australia
Using Artificial Intelligence to Screen for Hip Dysplasia
Not Applicable
Recruiting
- Conditions
- Developmental Dysplasia of Hip
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 240
- Registration Number
- NCT06647225
- Locations
- 🇦🇺
Royal Children's Hospital, Parkville, Victoria, Australia
Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)
Phase 2
Recruiting
- Conditions
- Cytomegalovirus Viraemia
- Interventions
- Drug: Standard dosing of IV ganciclovirDrug: Personalised dosing of IV ganciclovir
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 232
- Registration Number
- NCT06574789
- Locations
- 🇦🇺
Sydney Children's Hospital, Sydney, New South Wales, Australia
🇦🇺The Children's Hospital at Westmead, Sydney, New South Wales, Australia
🇦🇺Queensland Children's Hospital, Brisbane, Queensland, Australia
Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation.
Phase 2
Recruiting
- Conditions
- Solid Organ Transplant
- Interventions
- Diagnostic Test: Genotyping for CYP3A4 and CYP3A5 genesDevice: Use of NextDose platform
- First Posted Date
- 2024-07-31
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 45
- Registration Number
- NCT06529536
- Locations
- 🇦🇺
Royal Children's Hospital, Melbourne, Victoria, Australia